KDNY

Chinook Therapeutics, Inc. Common Stock
KDNY

Overview Fund Activity
Delisted

KDNY was delisted on the 10th of August, 2023.

Back to rankings

103 hedge funds and large institutions have $707M invested in Chinook Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 50 increasing their positions, 17 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
103
Holders Change
+18
Holders Change %
+21.18%
% of All Funds
1.59%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.06%
New
25
Increased
50
Reduced
17
Closed
7
Calls
$47K
Puts
$46K
Net Calls
+$1K
Net Calls Change
-$153K

Top Buyers

1
BI
1
BVF Inc
California
$29.4M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$38.4M
3
VA
3
VR Adviser
New York
$20.9M
4
SB
4
Samsara BioCapital
California
$74.9M
5
RCM
5
RA Capital Management
Massachusetts
$16.3M

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$5.72M
2
AC
2
Armistice Capital
New York
$16.9M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$6.01M
4
Citadel Advisors
4
Citadel Advisors
Florida
$203K
5
Two Sigma Investments
5
Two Sigma Investments
New York
$3.45M
Name Holding Trade Value Shares
Change 		Shares
Change %
OCA
26
Octagon Capital Advisors
New York
$8.16M +$8.16M +500,000 New
GPP
27
Great Point Partners
Connecticut
$6.36M +$6.36M +390,041 New
Renaissance Technologies
28
Renaissance Technologies
New York
$6.01M -$2.66M -162,920 -31%
Millennium Management
29
Millennium Management
New York
$5.72M -$5.12M -314,032 -47%
Northern Trust
30
Northern Trust
Illinois
$5.68M +$723K +44,339 +15%
Two Sigma Advisers
31
Two Sigma Advisers
New York
$5.17M -$1.02M -62,800 -17%
EAM
32
Erste Asset Management
Austria
$4.94M +$726K +45,000 +17%
SCM
33
Soleus Capital Management
Connecticut
$4.87M +$4.87M +298,700 New
Dimensional Fund Advisors
34
Dimensional Fund Advisors
Texas
$4.76M +$1.4M +86,052 +42%
IBT
35
International Biotechnology Trust
United Kingdom
$4.71M +$886K +54,389 +23%
Goldman Sachs
36
Goldman Sachs
New York
$3.56M +$380K +23,289 +12%
Bank of America
37
Bank of America
North Carolina
$3.55M +$22.4K +1,373 +0.6%
Two Sigma Investments
38
Two Sigma Investments
New York
$3.45M -$1.84M -112,853 -35%
Marshall Wace
39
Marshall Wace
United Kingdom
$3.05M +$3.05M +187,027 New
Ensign Peak Advisors
40
Ensign Peak Advisors
Utah
$3.04M +$1.35M +83,029 +81%
PAMP
41
Polar Asset Management Partners
Ontario, Canada
$2.97M +$2.97M +182,300 New
AG
42
Artal Group
Luxembourg
$2.94M – – –
Walleye Capital
43
Walleye Capital
New York
$2.88M +$2.88M +176,551 New
Nuveen Asset Management
44
Nuveen Asset Management
Illinois
$2.52M -$389K -23,819 -13%
Bank of New York Mellon
45
Bank of New York Mellon
New York
$2.31M +$195K +11,952 +9%
JPMorgan Chase & Co
46
JPMorgan Chase & Co
New York
$2.12M -$18.2K -1,114 -0.8%
D.E. Shaw & Co
47
D.E. Shaw & Co
New York
$2.09M +$1.56M +95,966 +299%
SFM
48
Sphera Funds Management
Israel
$1.82M +$1.82M +111,653 New
Charles Schwab
49
Charles Schwab
California
$1.67M +$286K +17,501 +21%
MIM
50
Monashee Investment Management
Massachusetts
$1.55M +$1.55M +95,000 New
1
2
3 4 5